Skip to main content

Prescribing guidance

All Wales adult asthma management and prescribing guideline
14/02/2024

This guideline aims to reduce variation in inhaler prescribing in the management of adult asthma and encourage consideration of the decarbonisation agenda of NHS Wales.

Primary care antimicrobial guidelines
24/01/2024

These guidelines aim to provide a simple effective, economical and empirical approach to the treatment of common infections; to minimise the emergence of bacterial resistance in the community.

All Wales COPD management and prescribing guideline
23/11/2023

This guideline aims to reduce variation in inhaler prescribing in the management of chronic obstructive pulmonary disease (COPD) and encourage consideration of the decarbonisation agenda of NHS Wales.

Endocrine management of gender incongruence in adults
11/08/2023

This prescribing guidance document is intended for non-specialist practitioners engaged in supporting the prescribing and monitoring of medical therapies used in the management of gender incongruence in adults (over 18 years old). 

All Wales Common Ailments Service formulary
01/08/2023

The Common Ailments Service aims to improve patient access to consistent, evidence-based advice for the management of common ailments. This document includes monographs for each of the ailments covered by the service.

Tramadol educational resources - 2021 review
07/07/2023

These educational resources aim to support the prescribing of tramadol in NHS Wales within the complex context of pain management.

All Wales paediatric asthma management and prescribing guidelines
21/06/2023

This document sets out the patient pathway for Wales, explicit in management options for each healthcare setting, referral thresholds, and national medication choices. It is a document for a national, standardised, safer and sustainable approach to asthma care in children.

Understanding unlicensed medicines
17/05/2023

The purpose of this document is to provide guidance for improving the management of unlicensed ‘specials’ and off-label medicines in all sectors of healthcare in NHS Wales. This guidance encompasses primary care (general practice and community pharmacy), secondary care, and patients and carers.

Resources for pharmacological management of pain
28/04/2023

These resources aim to support the prescribing of medicines used in NHS Wales for the management of pain. The resources include an analgesic stewardship guidance document, and documents advising on the pharmacological management of pain. These resources update and replace the items previously listed on our website as ‘Persistent Pain Resources’.

Polypharmacy in older people: A guide for healthcare professionals
08/03/2023

This resource has been created to help support medicines optimisation in older patients who may be subject to inappropriate polypharmacy

All Wales guidance for prescribing intervals
06/10/2022

This document presents an overview of the current situation regarding prescribing intervals, and sets out a series of recommendations on increasing prescribing intervals where appropriate.

Items identified as low value for prescribing in NHS Wales
29/09/2022

The aim of these documents is to minimise the prescribing of medicines that offer a limited clinical benefit to patients and where more cost effective treatments may be available.

Management of recurrent symptomatic urinary tract infection in adult women
05/07/2022

This guideline is aimed at all community and non-specialist medical, nursing and pharmacy staff involved in the prescribing and management of recurrent urinary tract infections (UTIs). This guideline is intended for non-pregnant, non-catheterised women aged 16 years and over.

Care home medicines optimisation toolkit
22/06/2022

The aim of the Care Home Medicines Optimisation Toolkit is to bring together a suite of guidance documents, tools and useful resources for care home staff and pharmacy teams who provide advice and support to care homes.

Management of Clostridioides difficile infection in Wales
16/03/2022

This guidance provides an evidence-based, accessible, antimicrobial prescribing strategy for managing Clostridioides difficile infection (CDI) in adults.

All Wales advice on oral anticoagulation for non-valvular atrial fibrillation
01/03/2022

This guidance focuses on treatment of patients with non-valvular atrial fibrillation (NVAF) and incorporates a risk/benefit assessment tool, and a one-page summary for Welsh healthcare practitioners choosing a direct oral anticoagulant in this patient population.

Prescribing dilemmas: A guide for prescribers
24/11/2021

This document provides guidance for healthcare professionals regarding prescribing duration, foodstuffs, complementary medicines and alternative therapies, common ailments, fertility treatment, erectile dysfunction, prescribing for self and family, visitors from overseas, travel and occupational health vaccines, prescribing situations not covered by the NHS including private care and private prescriptions, unlicensed medicines and prescribing outside national guidance.

All Wales advice on sodium-glucose cotransporter-2 (SGLT-2) inhibitors in type 2 diabetes and cardiovascular disease
30/09/2021

This guidance has been developed to help support healthcare professionals in the prescribing of SGLT-2 inhibitors in patients with type 2 diabetes mellitus and cardiovascular disease.

Material to support appropriate prescribing of hypnotics and anxiolytics across Wales
21/07/2021

This educational pack aims to support the appropriate prescribing of hypnotics and anxiolytics across Wales by providing key health professionals with a practical approach for the initiation and review of hypnotic and anxiolytic prescribing.

Welsh National Standards for Medication Review
02/06/2021

The Welsh National Standards for Medication Review have been developed to provide a structured approach to medication review and are benchmarks for quality, with the aim of optimising patient safety and prescribing practice.

Follow AWTTC: